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Through an RNAi-based screen for previously
uncharacterized regulators of genome stability,
we have identified the human protein C5orf45 as
an important factor in preventing the accumulation
of DNA damage in human cells. Here, we functio-
nally characterize C5orf45 as a binding partner of
the MRE11-RAD50-NBS1 (MRN) damage-sensing
complex. Hence, we rename C5orf45 as MRNIP
for MRN-interacting protein (MRNIP). We find
that MRNIP is rapidly recruited to sites of DNA
damage. Cells depleted of MRNIP display impaired
chromatin loading of the MRN complex, resulting in
reduced DNA end resection and defective ATM-
mediated DNA damage signaling, a reduced ability
to repair DNA breaks, and radiation sensitivity.
Finally, we show that MRNIP phosphorylation on
serine 115 leads to its nuclear localization, and this
modification is required for MRNIP’s role in promot-
ing genome stability. Collectively, these data reveal
that MRNIP is an important component of the human
DNA damage response.
INTRODUCTION
DNA double-strand breaks (DSBs) arise during natural cellular
processes, such as immunoglobulin gene rearrangement, repli-
cation fork collapse, and meiotic recombination (Kasparek and
Humphrey, 2011; Mehta and Haber, 2014). Likewise, exogenous
agents, including ionizing radiation (IR), radiomimetics, and
topoisomerase II inhibitors, such as etoposide, also cause
DSBs. If left unrepaired, DSBs pose a severe threat to genome
stability, leading to chromosomal rearrangements and fragmen-
tation (Kasparek and Humphrey, 2011). DSBs are either repaired
by non-homologous end-joining (NHEJ), an error-prone pathwayThis is an open access article undemployed throughout the cell cycle, or homologous recombina-
tion (HR), a cell-cycle-phase-specific mechanism that relies on
the presence of a correct template sequence on the unaffected
sister chromatid (Chapman et al., 2012).
The master kinase ATM is potently activated by DSBs, and
this process is dependent on the presence of an intact
MRE11-RAD50-NBS1 (MRN) complex (Dupre´ et al., 2006; Lee
and Paull, 2004; Paull, 2015; Shiloh and Ziv, 2013). As such,
cells derived from ataxia-telangiectasia-like disease (ATLD)
and Nijmegen breakage syndrome (NBS) patients that express
mutant forms of either MRE11 or NBS1, respectively, display
greatly reduced ATM activation and a predisposition to cancer
development (Uziel et al., 2003). In turn, ATM phosphorylates
NBS1, and this event is crucial for the formation of IR-induced
foci (IRIFs) (Lim et al., 2000). Activated ATM then drives the
cell-cycle checkpoint response to DSBs via a number of down-
stream targets, many of which are tumor suppressors, such as
TP53, BRCA1, and CHK2.
Here, we identify an uncharacterized protein, C5orf45, which
we rename MRNIP for MRN-interacting protein (MRNIP). We
show that MRNIP interacts with the MRN complex in part via a
conserved sequence also foundwithin theMRN interactionmotif
of the DSB-repair-promoting protein CtIP. MRNIP promotes
chromatin loading of MRN, and as such, MRNIP-deficient cells
exhibit reduced DNA end resection and defects in radiation-
induced ATM pathway activation, leading to increased DNA
damage and sensitivity to IR. We therefore define MRNIP as a
factor involved in cellular responses to DNA damage and high-
light that the human genome houses as yet uncharacterized
open reading frames with important cellular functions.
RESULTS
C5orf45 Is a Nuclear Protein that Prevents the
Accumulation of DNA Damage
We recently carried out a genome-wide small interfering RNA
(siRNA) screen in HCT116 colorectal carcinoma-derived cells
to identify previously uncharacterized regulators of genomeCell Reports 16, 1–11, September 6, 2016 ª 2016 The Author(s). 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. MRNIP Depletion Results in DNA Damage
(A) HeLa cells were transfected with control siRNA or individual siRNAs directed against MRNIP. After 72 hr, cell lysates were either analyzed by SDS-PAGE
followed by immunoblotting using the indicated antibodies (upper panel) or fixed and stained with an antibody recognizing gH2AX (middle panel showing
representative images). Cells were counterstained with DAPI, and cells with greater than five gH2AX foci were scored positive (graph in bottom panel). Data
shown represent the mean from three experimental repeats with their respective SEMs (*p% 0.05 compared to control siRNA-transfected cells).
(B) Cells were transfected as in (A) but stained for 53BP1 and counterstained with DAPI, and cells with greater than five 53BP1 foci were scored positive. Data
shown represent the mean from three experimental repeats with their respective SEMs (*p% 0.05 compared to control siRNA-transfected cells).
(C) Cells were transfected as in (A) and trypsinized, and an alkaline COMET assay was carried out. Tail moment was determined using COMET score software.
Data shown represent the mean from three experimental repeats with their respective SEMs (*p% 0.05 compared to control siRNA-transfected cells).
(D) (Upper panel) Representative images of HeLa cells stably expressing tetracycline-inducible YFP-tagged MRNIP, YFP-tagged 4A NLS, or 6A NLS mutant
MRNIP were treated with 1 mg/ml tetracycline for 24 hr and then fixed and stained with a GFP antibody. Nuclei were counterstained with DAPI, and representative
images are shown. DNA sequences below images show the basic amino acids (blue) in the NLS domain (amino acids [aas] 141–154), which aremutated to alanine
(red) in the respective 4ANLS and 6ANLSmutantMRNIP variants. (Lower panel) Quantification of the nuclear:cytoplasmic ratios of wild-type (WT) 4ANLS and 6A
NLS mutant YFP-MRNIP-expressing cells is shown. Data shown represent the mean from three experimental repeats with their respective SEMs (**p% 0.01 for
4A NLS compared to WT and *p% 0.05 for 6A NLS compared to 4A NLS).
(E) Representative images of YFP-MRNIP recruitment to sites of laser-induced micro-irradiation at the indicated times post-irradiation (white arrows show laser
track). Graph below shows quantification of average YFP-MRNIP recruitment at the indicated times post-irradiation from three independent experiments with
respective SEMs. The white scale bar represents 10 mM.
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Ser139 (gH2AX) as a marker of increased DNA damage (Staples
et al., 2012, 2014). From this screen, we identified C5orf45,
which yielded a relatively high Z score of 1.7. C5orf45 is a pre-
dicted 40-kDa protein that is well conserved in mammals, flies,
fish, and lizards but does not contain any known functional do-
mains and is predicted to be structurally disordered (clustal
omega, Pfam, and Phyre, respectively; data not shown),
although akin to several intrinsically disordered proteins, an or-2 Cell Reports 16, 1–11, September 6, 2016dered structural conformation could be adopted upon binding
an in vivo partner.
Efficient knockdown of C5orf45 was additionally confirmed
in HeLa cervical carcinoma cells using two individual siRNAs
that also resulted in an increased proportion of cells with
gH2AX and 53BP1 foci (Figures 1A and 1B, respectively),
thus validating the initial screen results and reducing the pos-
sibility of an off-target effect from a single siRNA. To assess
the presence of DNA damage more directly, we next carried
Please cite this article in press as: Staples et al., MRNIP/C5orf45 Interacts with the MRN Complex and Contributes to the DNA Damage Response, Cell
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orescence data, depletion of C5orf45 with two independent
siRNA resulted in a significant increase in COMET tail moment
(Figure 1C), indicating that C5orf45 does indeed have a role in
prevention the accumulation of DNA breaks within human
cells.
Due to the lack of good commercial C5orf45 antibodies for
immunofluorescence applications, we generated stable HeLa
cell lines expressing tetracycline-inducible yellow fluorescent
protein (YFP)-tagged C5orf45 to further assess its cellular local-
ization. Immunofluorescence analysis of these cell lines revealed
that C5orf45 is a nuclear protein (Figure 1D), which is consistent
with the presence of a predicted basic nuclear localization motif
(NLS) between residues 147 and 150 (Figure 1D). This was
further confirmed in cells expressing ectopic Myc-tagged
C5orf45 (Figure S1A). Mutation of this motif from RKRK to
AAAA (referred to as the 4A NLS mutant) led to a markedly
decreased nuclear localization of YFP-C5orf45 compared to
wild-type sequence (Figure 1D), indicating that this sequence
is indeed a functional NLS. We also hypothesized that two addi-
tional arginine residues nearby at positions 141 and 154 might
play a role in maintaining nuclear localization. Indeed, alanine
mutation of these residues on a 4A background (referred to as
the 6A NLS mutant) led to an additional decrease in C5orf45
nuclear localization (Figure 1D). Consistent with these data,
and the increased amounts of DNA damage in MRNIP-depleted
cells, YFP-MRNIP is rapidly recruited to sites of laser-induced
DNA damage (Figure 1E) with similar kinetics to known DNA
damage response proteins (Bekker-Jensen et al., 2006; Haince
et al., 2008).
C5orf45 Interacts with the MRN Complex
To gain further insight into the potential role of C5orf45 in the
preservation of genome stability through the efficient repair of
DNA breaks, we carried out proteomic analyses of purified
FLAG-tagged C5orf45 complexes immunoprecipitated from
stable cell lines. Among the main potential interactors were
all three members of the MRN DSB-sensing complex as well
as several substrates of the DDR regulator kinase ATM (Fig-
ure 2A). Due to the prevalence of MRN peptides present within
the purified C5orf45 complexes, we decided to rename
C5orf45 as MRNIP. We also identified peptides from a number
of MCM proteins (Figure 2A), including MCM8, which promotes
MRN-mediated resection of DNA breaks (Lee et al., 2015). To
validate these potential interactions, we analyzed FLAG-
C5orf45 immunoprecipitates and confirmed co-purification of
all three MRN complex members (Figure 2B). This was further
confirmed by an interaction between the MRN complex and
MRNIP in a stable HEK293 cell line expressing a tetracycline-
inducible form of N-terminally FLAG-tagged MRNIP (see Fig-
ure 2H). Furthermore, we confirmed that MRNIP endogenously
co-purifies with MRE11, RAD50, and NBS1 (Figure 2C). This
interaction was not enhanced by IR, suggesting a constitutive
interaction between MRNIP and the MRN complex (Figure 2C),
although we were unable to determine potential direct in-
teractions between MRNIP and the MRN complex due to inad-
equate amounts of soluble recombinant proteins due to poor
expression (data not shown). However, we also detected adose-dependent interaction between MRNIP and ionizing-radi-
ation-induced phosphorylated NBS1 (Figure 2D), supporting
the notion that MRNIP interacts functionally with core compo-
nents of the DDR.
As part of our sequence analysis of MRNIP, we identified three
SQ motifs at Ser100, Ser115, and Ser143 as potential sites for
phosphorylation by the phosphatidylinositol 3-kinase (PI3K)-
like kinases (PIKKs) ATM, ATR, or DNA-PK. To test whether
these residues are phosphorylated in response to DNA damage,
we immunoprecipitated FLAG-MRNIP from cells exposed to IR,
excised FLAG-MRNIP bands from SDS-PAGE gels, and
analyzed these by mass spectrometry. This revealed a weak
phosphorylation on Ser100, with a more-robust phosphorylation
on Ser115 (data not shown). To confirmMRNIP phosphorylation,
we immunoprecipitated FLAG-MRNIP from stable lines exposed
to IR and assessed phosphorylation using an antibody raised
against phospho-SQ/TQ peptides. The phospho-SQ/TQ anti-
body confirmed that MRNIP is phosphorylated, although in
contrast to MRNIP-associated NBS1, MRNIP phosphorylation
was not radiation dependent (Figure 2D). Interestingly, cross-
reactivity of the phospho-SQ/TQ antibody with MRNIP was not
diminished by mutation of either Ser100 or S115 to alanine alone
(data not shown) but was reduced in an MRNIP mutant in which
all three serine residues at 100, 115, and 143 had been mutated
to alanine (Figure S1B). Collectively, these data suggest that
MRNIP is constitutively phosphorylated on multiple sites in a
potentially redundant manner, albeit via a mechanism that is at
present unclear.
In further support of a functional phosphorylation event at
Ser115, alanine substitution of this residue resulted in re-locali-
zation of a significant portion of MRNIP from the nucleus to the
cytosol (Figure S1C). This is in contrast to Ser100, where a similar
alanine substitution had no effect on nuclear localization (data
not shown). Additionally, phospho-mimetic mutation of Ser115
to aspartic acid resulted in maintenance of nuclear localization
(Figure S1C), suggesting that the presence of a negatively
charged amino acid at Ser115 is required for nuclear retention.
To determine whether Ser100 and Ser115 phosphorylation are
important for the interaction with the MRN complex, we purified
wild-type, S100A, or S115A FLAG-MRNIP from tetracycline-
inducible HEK293 stable cell lines (we were unfortunately unable
to generate stable cell lines expressing similar levels of the
S143A mutant; data not shown). Interestingly, alanine substitu-
tion of either Ser100 or Ser115 resulted in a moderate decrease
in co-immunoprecipitation of MRE11, RAD50, and NBS1 (Fig-
ure 2E). Because these sites differentially affect MRNIP nuclear
localization, we conclude that the observed alteration in MRN
interaction is independent of this property. Finally, we investi-
gated whether any of the primary structural features of MRNIP
are involved in regulating its interaction with the MRN complex.
Immunoprecipitation of the FLAG-tagged 6A NLS mutant re-
vealed that the NLS is not essential for the interaction between
MRNIP and the MRN complex (Figure 2F), and in keeping
with this, RAD50 partially relocalizes from the nucleus to the
cytoplasm in cells overexpressing the 6A NLS MRNIP mutant
(Figure 2G). Close examination of the MRNIP amino acid
sequence revealed that MRNIP contains a short stretch of
amino acids (KELWS) with close homology to the start of a smallCell Reports 16, 1–11, September 6, 2016 3
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Figure 2. MRNIP Interacts with the MRN Complex via a Short Sequence Homologous to CtIP
(A) Parental HEK293 cells or HEK293 cells stably expressing FLAG-MRNIP were grown in large-scale culture. Cells were lysed, and FLAG-MRNIP was immu-
noprecipitated using the FLAGM2 antibody conjugated to agarose beads. FLAG-MRNIP was eluted using 150 ng/ml 33 FLAG peptide, and the resulting eluates
were boiled and resolved by SDS-PAGE and proteomic analysis carried out to identify interacting proteins. The number of unique peptides from putative
interactors is shown.
(B) A small-scale FLAG immunoprecipitation was performed as in (A) and eluates resolved by SDS-PAGE before probing with the indicated antibodies to confirm
interaction.
(C) HCT116 whole-cell lysates were prepared, and endogenous MRN complex members or MRNIP were individually immunoprecipitated, resolved by
SDS-PAGE, and probed with the indicated antibodies.
(D) Parental HEK293 cells or cells stably expressing FLAG-MRNIP were exposed to the indicated doses of IR and then lysed prior to FLAG immunoprecipitation.
Eluates (33 FLAG peptide) were resolved by SDS-PAGE and probed with the indicated antibodies.
(E) Cells stably expressing tetracycline-inducible WT, S100A, and S115A FLAG-MRNIP were grown, treated with 1 mg/ml tetracycline, and lysed prior to FLAG
immunoprecipitation/elution and blotting with the indicated antibodies. Quantification of these data reveals that the S100A and S115A MRNIP mutants exhibit
50%–80% reduced binding to the MRN complex compared to WT MRNIP.
(F) HEK293 cells were transiently transfected with an empty vector, wild-type, or DNLS6A FLAG-tagged MRNIP. After 24 hr, cells were lysed prior to FLAG
immunoprecipitation and blotting with the indicated antibodies.
(G) Representative images (left panel) and quantification (right panel) of the nuclear and cytoplasmic localization of RAD50 in U2OS cells transfected with
constructs expressing either wild-type YFP-tagged MRNIP cDNA or the 6A NLS mutant. The graph on the right shows quantification of the nuclear:cytoplasmic
ratios of YFP-MRNIP from three experimental repeats with their respective SEMs (**p% 0.01 compared to WT YFP-MRNIP-expressing cells).
(H) HEK293 cells stably expressing tetracycline-inducible full-length (FL) orD25 FLAG-MRNIPwere grown, treatedwith 1 mg/ml tetracycline, and, after 24 hr, were
lysed prior to FLAG immunoprecipitation and blotting with the indicated antibodies. Quantification of these data reveals that theD25mutant exhibits50%–70%
reduced binding to the MRN complex compared to WT MRNIP. The white scale bar represents 10 mM.
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which is involved in the interaction between CtIP and the MRN
complex (Yuan and Chen, 2009). To assess the potential role
of this motif in mediating interaction with the MRN complex,
we generated a 25-amino-acid FLAG-tagged deletion mutant4 Cell Reports 16, 1–11, September 6, 2016of MRNIP encompassing this sequence (D25). Immunopreci-
pitation studies revealed a significant decrease in interaction
between the D25 mutant and the MRN complex relative to
wild-type MRNIP (Figure 2H), suggesting that this sequence
may constitute a common MRN interaction motif.
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Breaks
The MRN complex has a well-established role in ATM activation
following DNA damage (Lee and Paull, 2004; Paull, 2015). There-
fore, we examined ATM pathway activation by assessing ATM
phosphorylation on Ser1981 and CHK2 on Thr68 via western
blotting of extracts fromMRNIP-depleted HCT116 cells exposed
to IR. Depletion of MRNIP depletion using two independent
siRNA resulted in a significant reduction in ATM phosphorylation
compared with cells transfected with control non-targeting
siRNA (Figure 3A). Likewise, IR-induced phosphorylation of the
ATM target KAP1 was similarly reduced inMRNIP-depleted cells
(Figure 3A), suggesting that ATM activity is compromised in
MRNIP-deficient cells. This is further evidenced by the inability
of MRNIP-depleted cells to fully activate a robust IR-induced
G2-M checkpoint (Figures 3B and S1E). Moreover, MRNIP-
depleted cells exhibited reduced IR-induced RAD51 foci forma-
tion and defective homology-based repair of DNA breaks
(Figures 3C and 3D, respectively). Consistent with these data,
an increased proportion of MRNIP-depleted cells failed to
resolve gH2AX foci following exposure to IR and consequently
exhibited increased formation of micronuclei (Figures 3E and
3F, respectively) and increased radiosensitivity (Figures 3G and
S1F), which were comparable to those observed in MRE11-
depleted cells (Figures S1G–S1J). As activated ATM phosphor-
ylates DNA-PK on Thr2609, an event required for maximal
end-joining efficiency and DNA repair (Chen et al., 2007), we
hypothesized that ATM-mediated phosphorylation of Thr2609
would be defective in MRNIP-depleted cells exposed to IR.
Indeed, depletion of MRNIP resulted in a significant decrease
in phospho-T2609-positive IR-induced nuclear foci (Figures
S2A and S2B). This phenotype was due to a reduction in the
ability of ATM to phosphorylate Thr2609, as co-depletion of
MRNIP and ATM failed to cause an additive decrease in
Thr2609 foci formation (Figure S2C). The MRN complex has
also been implicated in end processing and DNA break tethering
during NHEJ-mediated repair, independent of ATM activation
(Rass et al., 2009; Xie et al., 2009), although this minor role of
the MRN complex within end-joining processes is still poorly
defined. Interestingly, MRNIP-depleted cells exhibited a
reduced ability to re-ligate a BglII-digested construct by NHEJ
(Figure S2D), which was not associated with altered cell-cycle
distributions (Figure S2E) and is therefore likely a consequence
of reduced MRN activity. Collectively, these data suggest that
MRN function is reduced in MRNIP-depleted cells, leading to
defective ATM-dependent DNA damage signaling.
MRNIP Promotes the Chromatin Association of the MRN
Complex
As MRN-dependent resection of DNA breaks is important for
robust activation of ATM (Dupre´ et al., 2006; Lee and Paull,
2004; Paull, 2015), we next sought to assess whether MRNIP
is required for MRN-dependent DNA resection. To achieve
this, we used a recently developed system in which resection
at specific AsiSi restriction enzyme sites can be quantified by
qRT-PCR (Zhou et al., 2014). Similar to RAD50-depleted cells,
levels of resection were reduced by approximately 50% in
MRNIP-depleted cells compared to cells transfected with anon-targeting control siRNA (Figure 4A). As efficient chromatin
association and retention of the MRN complex is important for
DNA end resection and subsequent activation of ATM DDR
signaling, we assessed chromatin association of the MRN com-
plex by extracting chromatin-bound proteins from MRNIP-
depleted cells. Consistent with its nuclear localization, MRNIP
was present within the chromatin fraction in a similar abundance
to the nucleoplasmic fraction (Figure S3A). Interestingly, deple-
tion of MRNIP caused a marked reduction in chromatin-bound
MRN in untreated cells and MRN failed to accumulate on chro-
matin in MRNIP-depleted cells following exposure to IR (Fig-
ure 4B). Consistent with these findings, MRNIP-depleted cells
displayed a reduced number of radiation-induced RAD50 foci
(Figure S3B).
To investigate the contribution of MRNIP nuclear localization
and phosphorylation to its role in promoting MRN chromatin as-
sociation, we generated HCT116 lines with stably integrated
tetracycline-inducible FLAG-WT, FLAG-6A, and FLAG-S115A
MRNIP. In agreement with previous results, MRNIP depletion
using a siRNA targeted to the 30 UTR caused a reduction in
chromatin-bound MRN, which was rescued by tetracycline-
driven induction of wild-type MRNIP (Figure 4B). However, com-
parable depletion of MRNIP in nuclear localization-defective
FLAG-6A-expressing cells did not rescue MRN chromatin asso-
ciation (Figure 4C). Because RAD50 and NBS1 chromatin asso-
ciation was reduced in FLAG-6A-expressing cells relevant to the
wild-type-expressing cells, this phenotype may be somewhat
attributable to a dominant-negative effect resulting from small
amounts of leaky FLAG-6A expression in the absence of tetracy-
cline. Likewise, MRNIP depletion in the FLAG-S115A cell line
had no additional effect on the already reduced level of MRN
on chromatin (Figure 4D). However, the induction of Ser115A-
MRNIP caused a marked additional decrease of chromatin-
bound MRN, suggesting that Ser115 phosphorylation plays a
crucial role in directing MRNIP function (Figure 4D). Consistent
with these findings, ectopic expression of wild-type MRNIP,
but not the S115A or 6A mutants, was able to rescue DNA dam-
age accumulation, IR sensitivity or HR efficiency induced by
depletion of MRNIP with a UTR-directed siRNA (Figures 4E,
4F, and S3C, respectively). Similarly, the D25 mutant MRNIP,
which affects its ability to interact with the MRN complex (Fig-
ure 2H), was also unable to rescue these defects in MRNIP-defi-
cient cells (Figures 4E, 4F, and S3C, respectively). Collectively,
these data reveal that MRNIP, through its interaction with the
MRN complex, is required for robust cellular responses to DNA
breaks by promoting chromatin association of theMRN complex
and subsequent activation of the ATM-signaling cascade.
DISCUSSION
During our ongoing characterization of previously uncharacter-
ized genome maintenance factors highlighted by a genome-
wide siRNA screen, we identified MRNIP/C5orf45. Here, we
demonstrate that C5orf45 is an MRNIP that promotes chromatin
association and activity of the MRN complex to facilitate subse-
quent ATM-mediated DNA damage response signaling and
repair. Our data suggest that, althoughMRNIP is not an essential
part of this complex per se, it provides an important accessoryCell Reports 16, 1–11, September 6, 2016 5
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Figure 3. MRNIP Promotes ATM-CHK2 Signaling and Resistance to IR
(A) HCT116 cells were transfectedwith a non-targeting control siRNA or two individual siRNAs targetingMRNIP. After 72 hr, cells were exposed to IR (3 Gy) for the
indicated times before lysis and western blotting using the indicated antibodies. Quantification of these data reveals an30%–70% reduction in ATM substrate
phosphorylation at 1 hr post-IR in MRNIP-depleted cells compared to cells transfected with control siRNA.
(B) Assessment of IR-induced G2-M checkpoint in cells transfected with either control non-targeting or MRNIP-targeting siRNA. Shown is the fold increase in
mitotic cells in irradiated (2 Gy) MRNIP siRNA-treated cells compared to control siRNA-treated cells. Data shown represent the mean from three experimental
repeats with their respective SEMs (*p% 0.05 compared to control siRNA-transfected cells).
(C) IR-induced RAD51 foci in U2OS cells transfected with either control siRNA or two individual siRNAs targeting MRNIP. After 72 hr post-transfection, cells were
exposed to IR (3 Gy) fixed after the indicated times post-IR exposure and stained with a RAD51 antibody. Cells were counterstained with DAPI, and cells with
greater than five foci were scored as positive. Data shown represent the mean from three experimental repeats with their respective SEMs (*p% 0.05 and **p%
0.01 compared to control siRNA-transfected cells).
(D) HR frequency in HEK293 cells transfected with control siRNA or two individual siRNAs targetingMRNIP. After 48 hr, cells were transfected with either I-SceI or
DR-GFP constructs alone as negative controls or both I-SceI and DR-GFP constructs. After a further 24 hr, cells were trypsinized and the GFP-positive fraction
was assessed directly by flow cytometry. Data shown represent the mean from three experimental repeats with their respective SEMs (**p% 0.01 compared to
control siRNA-transfected cells).
(E) Cells were transfected as in (A), irradiated, and fixed after the indicated times before staining for gH2AX. Cells were counterstained with DAPI, and the number
of cells with greater than five foci were scored as above. Data shown represent the mean from three experimental repeats with their respective SEMs (*p% 0.05
compared to control siRNA-transfected cells).
(F) Cells were transfected and irradiated as in (A), and the percentage of cells with associated micronuclei was determined. Data shown represent the mean from
three experimental repeats with their respective SEMs (*p% 0.05 compared to control siRNA-transfected cells).
(G) Cells were transfected in 96-well plates as in (A) and exposed to IR (0, 1, or 2.5 Gy). After 5 days, survival was determined by MTT assay across three
independent experiments. Errors shown are SEMs. Comparable clonogenic survival curves are shown in Figure S1F.
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have shown that DNA damage accumulation in NBS1-deficient
cells is a consequence of the defective resolution of replication
fork intermediates (Bruhn et al., 2014), and our preliminary data6 Cell Reports 16, 1–11, September 6, 2016suggest that this may also be true in MRNIP-depleted cells as
evidenced by increased amounts of RPA foci in unstressed
MRNIP-depleted cells (data not shown) and the presence of
MCM factors in purified MRNIP complexes. In this regard,
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Figure 4. MRNIP Promotes MRN Chromatin Loading to Facilitate ATM-Mediated DDR Signaling
(A) Assessment of DNA end resection in U2OS AsiSi cell models (courtesy of Gae¨lle Legube) transfected with either control siRNA or two individual siRNAs
targeting MRNIP, with RAD50 siRNA serving as a positive control. The negative and positive control siRNA data represent cells treated with vehicle (ethanol) or
300 nM 4-hydroxytamoxifen, respectively, to induce a site-specific DNA break. The average percentage of ssDNA normalized to untreated controls for each
siRNA-treated population is shown from three independent experiments with their respective SEMs.
(B) HCT116 cells were transfected with non-targeting control siRNA or two individual siRNAs targeting MRNIP. After 72 hr, cells were exposed to IR (5 Gy) and
trypsinized after 45 min. Following collection by centrifugation, cells were fractionated, the chromatin-bound protein fraction resolved by SDS-PAGE, and blots
probed with the indicated antibodies. Quantification of these data reveals that MRNIP-depleted cells have between 50% and 80% less chromatin-bound MRN
complex compared with control siRNA-transfected cells.
(C) HCT116 cells stably expressing tetracycline-inducible FLAG-tagged WT or 6A NLS MRNIP were transfected with control siRNA or an siRNA directed against
the 30 UTR of MRNIP. After 24 hr, either vehicle or tetracycline was added to the cells. After a further 48 hr, cells were fractionated before chromatin extraction,
SDS-PAGE, and blotting using the indicated antibodies. Quantification of these data reveals that cells expressingWTMRNIP exhibit an average 2.7-fold increase
in chromatin-bound MRN complex compared with un-induced UTR siRNA-transfected cells, which is not replicated in cells expressing 6A NLS mutant MRNIP.
(D) HCT116 cells stably expressing tetracycline-inducible FLAG-tagged WT or S115A MRNIP were transfected with control siRNA or an siRNA directed against
the 30 UTR of MRNIP. After 24 hr, either vehicle or tetracycline was added to the cells. After a further 48 hr, cells were fractionated before chromatin extraction,
SDS-PAGE, and blotting using the indicated antibodies. Quantification of these data reveals that cells expressingWTMRNIP exhibit an average 2.4-fold increase
in chromatin-bound MRN complex compared with un-induced UTR siRNA-transfected cells, which is not replicated in cells expressing S115A mutant MRNIP.
(E) Quantification of gH2AX foci in HCT116 cells transfected with siRNA targeting the 30 UTR of MRNIP and the next day transfected with either an empty vector or
constructs expressing YFP-tagged WT or mutant MRNIP as indicated. After 48 hr, cells were fixed, stained with GFP and gH2AX antibodies, and counterstained
with DAPI. YFP-positive and YFP-negative populationswere scored for gH2AX foci (positive if they contained greater than five gH2AX foci). Data shown represent
the mean from three experimental repeats with their respective SEMs (**p% 0.01 compared to YFP-negative cells).
(F) IR clonogenic survival in parental Flp-In HeLa cells or derivative stably expressing tetracycline-inducible FLAG-tagged MRNIP cDNA as indicated. Cell
populations were all transfected with UTR-directed MRNIP prior to ectopic expression induction. Data shown are the average from at least three independent
experiments with their respective SEMs.
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interacting protein ATMIN, which can regulate ATM-mediated
responses to replication-associated DNA damage (Kanu et al.,
2016; Schmidt et al., 2014). It will therefore be interesting in
future studies to precisely assess such intermediates and the
fate of MRNIP-depleted cells both under non-stressed condi-
tions and in response to various DNA damage and replication-
stress-inducing stimuli.We also report here that the interaction between MRNIP and
the MRN complex is partially facilitated by a small domain with
similarity to the MRN-interaction motif found in CtIP, suggesting
that this may be a common MRN-interacting motif. We also
determine that MRNIP nuclear localization is mediated by a
basic NLS, which is in part directed by phosphorylation of
MRNIP at Ser115. Although this phosphorylation site is a poten-
tial target for PIKKs, we found no evidence for DNA damageCell Reports 16, 1–11, September 6, 2016 7
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an SQ/TQ-specific phospho-antibody, we detected constitutive
phosphorylation of MRNIP in the absence of any DNA-damaging
stimulus, which was only reduced when all three serine residues
at 100, 115, and 143 were mutated to alanine. Furthermore,
chemical inhibition of ATM, ATR, DNA-PK, Casein kinase 1
(CK1), or CK2 did not result in any discernible alteration to nu-
clear localization of MRNIP (data not shown). Therefore, the
identity of the kinase responsible for this phosphorylation event
onMRNIP currently remains elusive; however, further elucidating
how phosphorylation of MRNIP impacts its cellular function is
certainly worthy of further study. Finally, though neither the 6A
NLS nor the Ser115A mutant can rescue damage and repair
phenotypes caused by MRNIP depletion, it is important to note
that this may represent the consequences of the disruptive
effects observed following overexpression of these mutant
proteins, namely the cellular re-localization of MRN and/or its
displacement from chromatin.
Consistent with a core role in the repair of DNA DSBs, gener-
ation of mice with MRN-null alleles results in early embryonic
lethality (Luo et al., 1999; Zhu et al., 2001). Knockout mice of
the MRNIP homolog 3010026O09Rik have been generated as
part of the International Knockout Mouse Consortium (IMKC).
In contrast to MRN-null mice, MRNIP-null mice develop to
term, an observation in keeping with the relatively normal overall
levels of the MRN complex and the considerable residual ATM
activation observed in MRNIP-depleted cells. Interestingly,
MRNIP mutant homozygote males are completely infertile, a
phenotype associated with high levels of DNA damage in the
testis (Lewis and Simon, 2010). Staining of MRNIP in mouse tis-
sues also showed that MRNIP is highly expressed in the testis,
but not the ovary (IMKC data). These phenotypes are therefore
consistent with the accumulation of DNA damage in MRNIP-
deficient cells. The effects of the genetic ablation of murine
MRNIP on tumor incidence in mouse models of cancer and the
incidence of tumors in aged MRNIP-null mice might therefore
be worthy of investigation.
Deficiency in DDR proteins is causative for a range of human
disorders (Ciccia and Elledge, 2010; Jackson and Bartek,
2009). This includes the autosomal recessive conditions NBS,
ATLD, and NBS-like disorder (NBSLD), where the NBS1,
MRE11, and RAD50 genes, respectively, contain loss-of-func-
tion mutations (Ciccia and Elledge, 2010; Jackson and Bartek,
2009; O’Driscoll and Jeggo, 2006; Waltes et al., 2009). Symp-
toms are more severe in NBS and classical A-T compared to
ATLD and NBSLD and include microcephaly, neurodegenera-
tion, immunodeficiency, radiosensitivity, and predisposition to
cancer. Although comparable to siRNA depletion of MRE11,
MRNIP depletion does not phenocopy the drastic loss of MRN
components observed in ATLD, NBS, or NBSLD cells; one might
expect that any DDR-related disorder resulting from mutation or
loss of MRNIP function would have a much milder phenotype
than these severe conditions. Nonetheless, our data suggest
that disruption to MRNIP function could potentially contribute
to genome instability. Analysis of online cancer genomics re-
sources reveals that MRNIP is downregulated in several can-
cers, including head and neck squamous cell carcinoma, and
amplified in 18% of renal clear cell carcinomas, which may be8 Cell Reports 16, 1–11, September 6, 2016worth further study. In summary, we define MRNIP as a DDR
factor that promotes genome stability and highlight that the
human genome contains currently uncharacterized proteins
with important biological functions.
EXPERIMENTAL PROCEDURES
Antibodies
The antibodies used in this study are as follows: Abcam: C5orf45 (ab150917),
pATM Ser1981 (ab36810), total ATM (2C1; ab78), pDNA-PKcs Thr2609, GFP
(ab290), phospho-histone H3 Ser10 (ab14955), b-tubulin (ab7792), and b-actin
(ab8224); Cell Signaling Technologies: gH2AX Ser139 (no. 2577), phospho-
CHK2 (Ser68; no. 2661), Chk2 (no. 2662), total H3 (no. 4499); GeneTex:
RAD50 (13B3); Bethyl: phospho-KAP1 (Ser824; A300-767), KAP1 (A300-
274A), NBS1 (A300-187A); and R&D Systems: MRE1111. For flow cytometric
analysis of bromodeoxyuridine (BrdU) incorporation, mouse monoclonal
anti-BrdU (DAKO clone BU20a) was used, and this was visualized using rabbit
anti-mouse fluorescein isothiocyanate (FITC) (DAKO; F0232). For western
blotting, primary antibodies were visualized using horseradish peroxidase
(HRP)-conjugated secondary antibodies from DAKO. For immunofluores-
cence, Invitrogen anti-mouse or anti-rabbit Alexa 488 or 594 were used.
Cell Culture
HCT116, U2OS, RPE-1, HeLa, MRC5, and HEK293 cells were maintained as
an adherent monolayer in DMEM media containing 10% fetal bovine serum
(FBS) and 1% penicillin/streptomycin at 37C in a humidified atmosphere of
5% carbon dioxide. HeLa Flp-in T-Rex and HEK293 Flp-In T-Rex cells (Invitro-
gen) were maintained in DMEMmedia containing 10% FBS and 1% penicillin/
streptomycin, supplemented with 4 mg/ml Blasticidin S (Melford) and
100 mg/ml Zeocin (Invitrogen). HEK293 Flp-In cells weremaintained in identical
media supplemented with 100 mg/ml Zeocin (Invitrogen).
Cloning and Mutagenesis of C5orf45/MRNIP
MRNIP cDNA was purchased as a GateWay technology-compatible clone;
CCSB Human ORFeome c5orf45 (accession no. BC069051). This was used
directly to generate destination vectors expressing MRNIP with C-terminal
FLAG or GFP tags as outlined in the manufacturer’s instructions, and the clone
was used as a template for generation of MRNIP PCR products with stop co-
dons for the generation of vectors encoding N-terminally tagged MRNIP. Site-
directed mutagenesis was carried out using appropriate mutagenic primers in
a KOD polymerase-based PCR reaction using the p221DONR-MRNIP clone
as a template, and the PCR product was digested overnight using DpnI before
bacterial transformation and sequence verification using M13 primers.
Mutants were then recombined into GateWay destination vectors as outlined
in the manufacturer’s instructions prior to generation of stable cell lines.
Stable Cell Line Generation
Stable tetracycline-inducible HEK293 and HeLa Flp-In cell lines expressing
FLAG- or YFP-tagged C5orf45 were created by co-transfection of these cell
lines with pPGKFLPobpA-Flp recombinase and either empty pDEST-YFP/
FRT/TO-C5orf45 or pDEST-Flag/FRT/TO-C5orf45 according to the Flp-In
manufacturer’s protocol. Recombinants were then selected in media contain-
ing 4 mg/ml Blasticidin S and 150 mg/ml Hygromycin B for HeLa cells or
15 mg/ml Blasticidin S and 100 mg/ml Hygromycin B for HEK293 cells (Invitro-
gen). All transient transfections were performed using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions.
Transfections and Drug Treatments
Cells were transfected with 50 nM siRNA using Lipofectamine 2000 (Invitro-
gen) according to the manufacturer’s instructions. Cells were collected, lysed,
or fixed for analysis after 72 hr unless otherwise indicated.
Cell Lysis and Western Blotting
For whole-cell extracts, the cells were solubilized on ice in lysis buffer (20 mM
Tris-HCl [pH 7.5], 150mMNaCl, 1% Triton X-100, 1mMDTT, and 1mMEDTA)
supplemented with 50 U/ml Benzonase (Novagen), protease, and phosphatase
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resulting samples at 16,000 g for 15 min at 4C. Gel electrophoresis was per-
formed using the NuPAGE system (Invitrogen). Briefly, samples were resolved
on 4%–12% Bis-Tris gels in MOPS buffer and transferred to a polyvinylidene
fluoride (PVDF) membrane, which was then probed for the protein of interest
using antibodies diluted in PBS containing 5% Marvel or 3% BSA and 0.1%
Tween-20 (Sigma). Images of non-saturated protein bands were quantified
using ImageJ and normalized to appropriate loading controls.
Subcellular Fractionation
Cells were trypsinized, washed twice in PBS, and re-suspended in buffer A
(10% glycerol, 0.34 M sucrose, 1% Triton X-100, 10 mM HEPES, 10 mM
KCl, 10 mM MgCl2, 1 mM EDTA, 1 mM DTT, and protease and phosphatase
inhibitors). After 10 min, cells were spun at 1,000 g, the supernatant (S1 frac-
tion) was collected, and then the pellet was washed once in buffer A. Buffer B
(10 mM HEPES, 3 mM EDTA, 0.2 mM EGTA, and protease and phosphatase
inhibitors) was then added. After 30 min, cells were spun at 1,500 g, the
supernatant collected (S2 fraction), and the pellet washed in buffer B. The
remaining pellet was re-suspended in buffer A lacking glycerol and containing
500 units/ml Benzonase. After 1 hr, material was pelleted at 1,500 g and the
supernatant (S3 fraction) was collected.
Immunoprecipitation
For purification of FLAG-tagged proteins, 1 mg of the whole-cell extract was
incubated with 20 ml of M2-anti FLAG beads (Sigma) for 16 hr at 4C. For
immunoprecipitations using endogenous antibodies, 2 mg of antibody was
incubated with the sample for 1 or 2 hr before addition to 20 ml of washed pro-
tein A/G beads (Santa Cruz Biotechnology) and incubation for 16 hr at 4C.
Beads were then pelleted and washed three times in 203 bed volume of the
lysis buffer. The bound protein was eluted either by heating the beads at
95C for 5 min with 23 LDS buffer (Invitrogen) or by incubation with FLAG
peptide (Sigma) according to manufacturer’s instructions. Inputs represent
1/40th of the extract used for the immunoprecipitation.
Flow Cytometry Analyses
Cell populations were washed in PBS and fixed overnight in 70% ethanol at
20C. Fixed samples were washed three times in PBS before treatment
with 5 mg of DNase1 followed by the addition of 300 ml of propidium iodide
(50 mg/ml) to each sample. Fluorescence-activated cell sorting (FACS) acqui-
sition was carried out using a FACS-Calibur (Becton Dickinson) and analyzed
by FlowJo (Tree Star). On average, 20,000 live cells were gated and quantified
for each sample, with each condition replicated two or three times for each in-
dividual experiment. For quantification of phospho-histone H3 on Ser10 to
assess the IR-induced G2-M checkpoint, HCT116 cells were transfected
with a control siRNA or two individual siRNAs targeting MRNIP. After 72 hr,
cells were exposed to IR (2 Gy) and, after a further 2 hr, were fixed and stained
with a phospho-H3Ser10 antibody and propidium iodide. Cells were analyzed
by flow cytometry, and the proportion of cells positive for Ser10 phosphoryla-
tion was determined by flow cytometry following staining with an anti-pH3
antibody (Cell Signaling; 9701) and counterstaining with propidium iodide as
previously described (Collis et al., 2008).
Immunofluorescence and Live-Cell Imaging
Cells were grown on glass coverslips and treated as indicated and then fixed
with either methanol or 3%buffered paraformaldehyde for 10min at room tem-
perature (RT) and permeabilized in PBS containing 0.5% Triton X-100 for 5min
at RT. Cells were then incubated with primary antibody for 2 hr at RT and de-
tected with a secondary Alexa-488- or Alexa-594-conjugated goat anti-rabbit
or anti-mouse immunoglobulin G (IgG). Antibody dilutions and washes after in-
cubations were performed in PBS. DNA was stained with DAPI (1 mg/ml), and
coverslips weremounted in Shandon Immu-Mountmedium (Thermo). Fluores-
cence microscopy was performed on a Nikon Eclipse T200 inverted micro-
scope (Melville), equipped with a Hamamatsu Orca ER camera and a 200 W
metal arc lamp (Prior Scientific) with a 1003 objective lens, and images
were captured and analyzed using Volocity 3.6.1 software (Improvision). In
general, scoring for each individual condition within an experiment was carried
out on at least ten separate fields of view containing between 200 and 300 cellsin total, and means from at least three independent experiments were calcu-
lated and plotted with their respective SEMs. Laser-induced micro-irradiation
was carried out as previously described (Gibbs-Seymour et al., 2016).
Statistical Analyses
Statistically significant differences between cell populations was confirmed
using a two-tailed t test, assuming equal variances, and are presented on
figures as *p% 0.05 and **p% 0.01.
Clonogenic Survival Assay
Cells were transfected with RNAi and then, after 48 hr, were trypsinized and
1,000 cells replated onto 10-cm tissue culture dishes in duplicate for each con-
dition. After a further 24 hr, cells were treated with drug or exposed to IR before
incubation for a further 10–12 days. Cells were stained with Methylene Blue
and rinsed with water. Colonies were counted and survival curves calculated,
normalizing for plating efficiency in untreated controls for each transfection.
Results were plotted as percentage survival.
MTT Growth Assay
Cells were plated at a density of 1,500 cells/well on 96-well plates, and the
following day, these were transfected with siRNA as indicated above. After
the indicated times, MTT reagent was added to the cells at a final concentra-
tion of 1 mg/ml, and these were incubated at 37C for 3 hr. The media was
removed and replaced with 200 ml DMSO to solubilize the formazan product,
and the absorbance of this product was assessed by quantifying optical
density at 540 nm using a spectrophotometric microtiter plate reader.
NHEJ Assay
Cells were scraped and re-suspended in 300 ml of buffer I (10 mM HEPES,
10 mM KCl, 1.5 mMMgCl2, 500 mM PMSF, 1 mM DTT, and protease inhibitor;
Roche) and incubated on ice for 15 min. Six microliters of 10% Nonidet P-40
were added to the cell lysates and vortexed for 5–10 s. Nuclear pellets were
prepared by centrifuging at 6,0003 g for 5 min. The nuclear pellet was re-sus-
pended in 50 ml of buffer II containing 20 mM HEPES, 0.42 M NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, and 25% v/v glycerol. After 40 min, the nuclear extracts
were centrifuged at 13,0003 g for 10 min at 4C. The protein concentration of
the extracts was determined via Bradford reagent (Bio-Rad) according to the
manufacturer’s instruction. The nuclear extracts were stored at 80C. Line-
arized pDsRed2ER plasmid substrates were generated by digestion with BglII
and purified using QIAGEN gel extraction kit. One hundred fifty nanograms of
substrates were incubated with 0, 2, or 4 mg of nuclear protein extracts in the
E-J reaction buffer (1 mM ATP, 0.25 mM dNTP, 25 mM Tris acetate, 100 mM
potassium acetate, 10 mMmagnesium acetate, 1 mM DTT [pH 7.5]) for 1 hr at
37C. The reaction was treated with 1 mg/ml proteinase K at 65C for 30 min
and then electrophoresed on a 0.7% agarose gel. DNA was detected by EtBr
staining.
HR Assay
Forty-eight hours after siRNA transfection, HEK293 cells were transiently
transfected with either pDR-GFP alone, I-SceI plasmid alone, or both plasmids
in combination. For rescue experiments, parental DR-GFP U2OS cells or cells
stably expressing FLAG-MRNIP were transfected with a control siRNA or a
UTR-directed MRNIP siRNA, followed by transfection with an I-SceI expres-
sion vector. Twenty-four to seventy-two hours later, cell populations were
trypsinized, fixed in ethanol, and immediately processed on a BD LSR II
FACS machine for the presence of GFP, using DR-GFP-only transfected cells
to set the baseline. Alternatively, U2OS DR-GFP cells were transfected siRNA
and 6 hr later, transfected with a plasmid encoding the I-SceI meganuclease.
The next day, the media was refreshed, and after a further 48 hr, cells were
trypsinized and analyzed for GFP positivity by flow cytometry using a Partec
CyFlow Cube8 cytometer. At least 100,000 cells were counted per sample.
Resection Assay
Quantitation of DSB resection in U2OS ER-AsiSi cells was performed accord-
ing to the protocol established by the Paull lab (Zhou et al., 2014). After 72 hr
post-siRNA transfection, cells were treated with vehicle (ethanol) or 300 nM
4-hydroxytamoxifen. Four hours later, cells were trypsinized, re-suspendedCell Reports 16, 1–11, September 6, 2016 9
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3 days. The agar ball was then washed with 0.5 M EDTA, 2% N-lauroylsarco-
sine, 1 mg/ml proteinase-K, 1 mM CaCl2, pH 8.0 (ESP), 1.85 M NaCl, 0.15 M
KCl, 5mMMgCl2, 2mMEDTA, 4mMTris, 0.5% Triton X-100, pH 7.5 (HS), and
phosphate buffers beforemelting and re-suspension in the appropriate restric-
tion enzyme buffer. Genomic DNA (20 ml) was then either digested or mock
digested with 20 units of restriction enzymes (BsrGI or HindIII-HF; New
England Biolabs) at 37C overnight. Twenty nanograms of these samples
were used in qPCR reactions run on an Abi 7900 Real-Time PCR System.
The Ct value of the mock-digested sample was subtracted from the Ct value
of the digested sample, and the percentage of single-stranded DNA (ssDNA)
was calculated using the formula: ssDNA% = 1/(2^ (DCt  1) + 0.5) 3 100.
Alkaline COMET Assay
COMET assays were performed using the Trevigen kit system according to the
manufacturers’ protocol. Briefly, cells were re-suspended at 13 105 per ml in
low-melting-point agarose and transferred to the COMET slide. After setting,
slideswere incubated for 30min in lysis solution and then in unwinding solution
for 20 min. Slides were then electrophoresed at 21 V for 30 min before rinsing
twice in water and once in 70% ethanol. After drying, cells were stained with
SYBR Green and visualized by fluorescence microscopy. Tail area and
moment were analyzed from 100 cells per condition using COMETScore
software from three independent experiments.
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Supplementary Figure S1. Related to Figures 2 and 3. 
A: Representative images of HeLa cells transfected with myc-MRNIP or YFP-MRNIP 
and either mock-irradiated or exposed to ionising radiation (3 Gy). After 1 hr, cells 
were fixed, stained with an anti-GFP antibody, and counterstained with DAPI. B: 
Indicated western blots on FLAG IP/eluates from cell extracts derived from cells 
stably expressing either WT or a S100A/S115AS143A triple mutant FLAG-MRNIP. C: 
Representative images of HeLa cells stably expressing tetracycline-inducible WT, 
S115A or S115D MRNIP, treated with 1 µg/ml tetracycline, fixed after 24 hrs and 
stained as in (A). D: Sequence alignment of CtIP and MRNIP, encompassing the 
conserved region that promotes interaction with MRN. E: Assessment of the IR-
induced G2-M checkpoint by CDC25A degradation in cells transfected with either 
control non-targeting or MRNIP-targeting siRNA as indicated. Cells were treated with 
cycloheximide (10 µg/ml) 72 hours post-transfection, exposed 5Gy IR and protein 
extracts collected at the indicated times. F: HCT116 cells were transfected as in 
Figure 3G, and after 48 hrs were trypsinised and re-plated onto 10 cm culture dishes. 
The following day, cells were either mock irradiated or exposed to the indicated 
doses of ionising radiation. After 10 days, colonies were counted, normalised for 
plating efficiency and displayed as a percentage survival. Experiments were 
performed three times, and the standard errors of the mean are shown. G-J: 
Quantified IR-induced pATM (Ser1981), γH2AX (Ser139), micronuclei and 
clonogenioc survival in cells treated with either control or MRE11 siRNA respectively. 
For all data presented in these Figures, HCT116 cells were transfected as described 
in Figure 3 but with either control non-targeting or MRE11-trageting siRNA. Data 
shown represents the mean from three experimental repeats with their respective 
SEMs (*p≤0.05 and **p≤0.01 compared to control siRNA transfected cells). White 
scale bar 10µM. 
 
Supplementary Figure S2. Related to Figure 3. 
A: Left panel; representative images of HCT116 cells transfected and irradiated as in 
(A), then fixed and stained with an antibody recognising DNA-PK phosphorylated on 
Thr2609 (which we validated by western blot analyses; supplementary Figure S2B). 
Cells were counterstained with DAPI, and the number of cells with >5 phospho-
Thr2609 foci were counted. Right panel; quantification of percentage of siRNA-
transfected cell populations exhibiting pDNA-PK foci at the indicated times post 3Gy 
IR. Data shown represents the mean from three experimental repeats with their 
	  	   2 
respective SEMs (*p≤0.05 compared to control siRNA transfected cells). B: Western 
blots validating specificity of the pDNA-PK (T2609) antibody and complementing the 
immunofluorescence data in Figure S2A. Black arrows indicate the highlighted 
protein band. C: Quantification of pDNA-PK foci (Thr2609) in HCT116 cells 
transfected with either control siRNA, two individual MRNIP siRNAs, ATM siRNA, or 
both MRNIP and ATM siRNAs. After 72 hrs, cells were mock-irradiated or exposed to 
ionising radiation (3 Gy) and 1 hr later were fixed and stained using a phospho-
Thr2609 DNA-PK antibody. Cells were counterstained with DAPI, and cells with >5 
foci were scored as positive. Data shown represents the mean from three 
experimental repeats with their respective SEMs (**p≤0.01 compared to control 
siRNA transfected cells). D: Plasmid-based NHEJ assay in HCT116 cells transfected 
with control siRNA or two MRNIP siRNAs, and after 72 hrs nuclear extracts were 
prepared. Either 0, 2 or 4 µg of nuclear extract was added to 150 ng of Bgl II-
digested DSRed plasmid. After 30 min the reaction was stopped and the products 
resolved by agarose gel electrophoresis. Each experiment was performed at least 
three times, and representative figures are shown. Errors shown are standard errors 
of the mean. E: Cell cycle analyses in HCT116 cells transfected with either control 
siRNA, or two individual siRNAs targeting MRNIP. After 72 hrs, cells were 
trypsinised, fixed in ethanol, stained with propidium iodide and analysed by flow 
cytometry. The proportion of cells in each cell cycle phase is shown. These data 
show that the NHEJ defects observed in MRNIP-depleted cells are not a 
consequence of cell cycle changes. White scale bar 10µM. 
  
Supplementary Figure S3. Related to Figure 4. 
A: U2OS cells were transfected with control siRNA, or two independent MRNIP 
siRNAs. After 48 hrs, cells were either mock-irradiated or exposed to ionising 
radiation (3 Gy). After 45 mins, cells were trypsinised and fractionated, and the 
chromatin fraction released by benzonase treatment. Extracts were resolved by SDS-
PAGE and probed using the indicated antibodies. ORC2 was used to confirm 
efficient separation of the nucleoplasmic and chromatin-containing fractions. B: 
Representative images (left panel) and quantification (right panel) of 3Gy IR-induced 
RAD50 foci in HCT116 cells transfected with either control siRNA, or two individual 
siRNAs targeting MRNIP. Cells were scored positive if they exhibited >5 Rad50 foci. 
Data shown represents the mean and SEMs from three independent experiments. C: 
Left panel: representative western blot showing expression of FLAG-tagged MRNIP 
	  	   3 
in the indicated U2OS stable cell lines. Right panel; Quantification of relative HR in 
parental DR-GFP U2OS cells or cells stably expressing FLAG-MRNIP following 
transfection with either control siRNA or an UTR-directed MRNIP siRNA. Data shown 
represents the mean from three experimental repeats with their respective SEMs 
(**p≤0.01 compared to respective control siRNA-transfected population). White scale 
bar 10µM. 
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